Cargando…
Pembrolizumab-induced toxic epidermal necrolysis: case report
A 63-year-old man with metastatic lung adenocarcinoma presented with biopsy confirmed toxic epidermal necrolysis (TEN). Symptoms commenced following 3 cycles of carboplatin, pemetrexed and pembrolizumab, with the first cycle given ~9.5 weeks prior to presentation. The patient was managed with immuno...
Autores principales: | Chow, Kar Ven Cavan, O’Leary, Connor, Paxton-Hall, Fiona, Lambie, Duncan, O’Byrne, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931819/ https://www.ncbi.nlm.nih.gov/pubmed/35317001 http://dx.doi.org/10.1093/omcr/omac025 |
Ejemplares similares
-
Pembrolizumab-Induced Toxic Epidermal Necrolysis
por: Borg, Luca, et al.
Publicado: (2022) -
Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
por: Qiu, Connie, et al.
Publicado: (2020) -
Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis
por: Kian, Waleed, et al.
Publicado: (2021) -
Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014) -
Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)